Quarterly Statement Of Cash Flows

EnBio Holdings,Inc - Filing #7325108

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,067,467,000 JPY
2,597,032,000 JPY
Interest and dividends received
30,994,000 JPY
28,944,000 JPY
Interest paid
-115,599,000 JPY
-125,601,000 JPY
Net cash provided by (used in) operating activities
1,663,431,000 JPY
1,989,080,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,079,075,000 JPY
-1,162,712,000 JPY
Purchase of investment securities
-1,888,000 JPY
-23,685,000 JPY
Loan advances
-280,085,000 JPY
-552,456,000 JPY
Other, net
-27,858,000 JPY
-17,246,000 JPY
Net cash provided by (used in) investing activities
-1,583,696,000 JPY
-1,770,420,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
1,987,400,000 JPY
1,349,902,000 JPY
Repayments of long-term borrowings
-2,498,317,000 JPY
-1,208,477,000 JPY
Redemption of bonds
-36,500,000 JPY
-35,000,000 JPY
Proceeds from issuance of shares
1,056,000,000 JPY
JPY
Dividends paid
-52,965,000 JPY
-52,892,000 JPY
Net cash provided by (used in) financing activities
638,922,000 JPY
240,727,000 JPY
Effect of exchange rate change on cash and cash equivalents
7,821,000 JPY
-2,368,000 JPY
Net increase (decrease) in cash and cash equivalents
726,478,000 JPY
457,019,000 JPY
Cash and cash equivalents
3,574,064,000 JPY
2,798,635,000 JPY
2,341,616,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.